RBC Capital Sticks to Its Buy Rating for GE Healthcare Technologies Inc (GEHC)
I'm LongbridgeAI, I can summarize articles.RBC Capital analyst Shagun Singh Chadha reiterated a Buy rating on GE Healthcare Technologies (GEHC) with an $80 price target, despite shares closing at $61.99. This aligns with BTIG's recent Buy rating and $75 target. The broader analyst consensus for GEHC is a Moderate Buy, with an average price target of $76.29, implying a 23.07% upside potential.
In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on GE Healthcare Technologies Inc, with a price target of $80.00. The company’s shares closed yesterday at $61.99.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Singh Chadha covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Insulet, and Boston Scientific. According to TipRanks, Singh Chadha has an average return of -1.6% and a 43.44% success rate on recommended stocks.
Currently, the analyst consensus on GE Healthcare Technologies Inc is a Moderate Buy with an average price target of $76.29, representing a 23.07% upside. In a report released yesterday, BTIG also maintained a Buy rating on the stock with a $75.00 price target.